Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation.

Korean J Intern Med · 2026 · PMC12800467 · PMID 41531219

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among patients aged > 70 years, both warfarin (aHR, 1.07 [0.56–2.04]; p for interaction = 0.002) and DOACs (aHR, 1.02 [0.52–2.00]; p for interaction = 0.002) showed a trend toward lower MB risk relative to the corresponding treatments in patients aged < 70 years.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.